Aegerion Pharmaceuticals, Inc. to Announce Second-Quarter 2013 Financial Results on Tuesday, July 30
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
CAMBRIDGE, Mass., July 12, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating, often fatal, rare diseases, announced that the Company will host a conference call and live audio webcast at 8:30 a.m. EDT on Tuesday, July 30, 2013, to provide a business update and to discuss its second-quarter financial and operational results.
Help employers find you! Check out all the jobs and post your resume.
CAMBRIDGE, Mass., July 12, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating, often fatal, rare diseases, announced that the Company will host a conference call and live audio webcast at 8:30 a.m. EDT on Tuesday, July 30, 2013, to provide a business update and to discuss its second-quarter financial and operational results.
Help employers find you! Check out all the jobs and post your resume.